|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/52 | |
| C12N 5/10 | |||
| C12N 15/867 | |||
| C07K 14/39 | |||
| C12N 9/10 | |||
| C07K 14/55 | |||
| C07K 14/57 | |||
| C12N 9/78 |
| (11) | Patento numeris | 2346995 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09820986.9 |
| Europos patento paraiškos padavimo data | 2009-09-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-07-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/058510 |
| Data | 2009-09-26 |
| (87) | Numeris | WO 2010/045002 |
| Data | 2010-04-22 |
| (30) | Numeris | Data | Šalis |
| 186823 P | 2009-06-13 | US | |
| 100666 P | 2008-09-26 | US | |
| 120618 P | 2008-12-08 | US |
| (72) |
GRUBER, Harry, E., US
JOLLY, Douglas, US
PEREZ, Omar, US
LOGG, Christopher R., US
|
| (73) |
Tocagen Inc.,
3030 Bunker Hill Street Suite 230, San Diego, CA 92109,
US
|
| (54) | GENE THERAPY VECTORS AND CYTOSINE DEAMINASES |
| GENE THERAPY VECTORS AND CYTOSINE DEAMINASES |